论文部分内容阅读
Objective To observe the efficacy of Sorafenib in preventing and treating tumor recurrence after liver trans-plantation for patients with primary hepatic carcinoma beyond Milan criteria. Methods From March 2008 to June 2010,30 patients of liver transplantation with primary hepatic carcinoma exceeding Milan criteria were
Objective To observe the efficacy of Sorafenib in preventing and treating tumor recurrence after liver trans-plantation for patients with primary hepatic carcinoma beyond Milan criteria. Methods From March 2008 to June 2010, 30 patients of liver transplantation with primary hepatic carcinoma exceeding Milan criteria were